Organization · Venture Capital
Pivotal Life Sciences
Pivotal Life Sciences is a global healthcare investment firm based in San Francisco, specializing in capital provision for innovative therapeutic companies. It focuses on transformative healthcare solutions across North America and Europe.
Overview
What Pivotal Life Sciences does
What Pivotal Life Sciences is
Pivotal Life Sciences is a global healthcare investment firm based in San Francisco, specializing in capital provision for innovative therapeutic companies. It focuses on transformative healthcare solutions across North America and Europe.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Pivotal Life Sciences elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pivotal Life Sciences as a funder
Investment thesis
Pivotal Life Sciences invests in therapeutics companies at major de-risking value inflection points, focusing on transformative solutions for unmet medical needs.
Focus narrative
Pivotal Life Sciences targets transformative therapeutic-focused healthcare companies, particularly those nearing significant de-risking value inflection points. The firm emphasizes high-impact therapeutics with the potential for near-curative or transformative disease management, supporting companies from creation through clinical development and commercialization.
Value beyond capital
Pivotal Life Sciences adds value to its portfolio companies by actively participating in company building, leveraging its expertise in therapeutics development, and providing strategic guidance through board involvement. The firm also utilizes data analytics and AI tools for deal sourcing, selection, diligence, and portfolio management.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Series C · Series D · Growth Equity · Ipo
- Regions
- North America · Europe · Greater China
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
MapLight Therapeutics: A clinical-stage CNS therapeutics company that raised $372.5 million in Series D funding. Evommune: A clinical-stage immunology company involved in a $115 million Series C financing. Vaxcyte: A vaccine developer with a strong portfolio. Karuna Therapeutics: A therapeutics company focused on innovative solutions. Arcutis Therapeutics: Specializes in dermatology therapeutics. Inozyme: A rare disease biopharma company recently acquired by BioMarin.
Common questions
What to know about Pivotal Life Sciences
Upseed classifies Pivotal Life Sciences under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.